Supplemental material
Journal of Enzyme Inhibition and Medicinal Chemistry
Volume 34, 2019 - Issue 1
Related Research Data
IDO inhibitors move center stage in immuno-oncology
Source:
Springer Science and Business Media LLC
Design, synthesis and biological evaluation of novel naphthoquinone derivatives as IDO1 inhibitors.
Source:
Elsevier BV
Indoleamine 2,3-Dioxygenase Expression in Human Cancers: Clinical and Immunologic Perspectives
Source:
American Association for Cancer Research (AACR)
Abstract 491: NLG919, a novel indoleamine-2,3-dioxygenase (IDO)-pathway inhibitor drug candidate for cancer therapy.
Source:
American Association for Cancer Research
Crystal structure of human indoleamine 2,3-dioxygenase: catalytic mechanism of O2 incorporation by a heme-containing dioxygenase.
Source:
Proceedings of the National Academy of Sciences
IDO expression by dendritic cells: tolerance and tryptophan catabolism.
Source:
Springer Science and Business Media LLC
Discovery of tryptanthrin derivatives as potent inhibitors of indoleamine 2,3-dioxygenase with therapeutic activity in Lewis lung cancer (LLC) tumor-bearing mice.
Source:
American Chemical Society (ACS)
Minor Groove Binders and Drugs Targeting Proteins Cover Complementary Regions in Chemical Shape Space
Source:
American Chemical Society (ACS)
Indoleamine 2,3-dioxygenase, an emerging target for anti-cancer therapy.
Source:
Bentham Science Publishers Ltd.
Synthesis of selectively trifluoromethylated pyridine derivaties as potential antihypertensives
Source:
Wiley
Inhibition of Indoleamine 2,3-Dioxygenase in Dendritic Cells by Stereoisomers of 1-Methyl-Tryptophan Correlates with Antitumor Responses
Source:
American Association for Cancer Research (AACR)
Development and validation of a genetic algorithm for flexible docking.
Source:
Elsevier BV
Identification and optimization of novel Hsp90 inhibitors with tetrahydropyrido[4,3-d]pyrimidines core through shape-based screening
Source:
Elsevier BV
IDO as a drug target for cancer immunotherapy: recent developments in IDO inhibitors discovery
Source:
Royal Society of Chemistry (RSC)
Abstract 4863: PF-06840003: a highly selective IDO-1 inhibitor that shows good in vivo efficacy in combination with immune checkpoint inhibitors
Source:
American Association for Cancer Research
IDO and tolerance to tumors.
Source:
Elsevier BV
Oren-gedoku-to and its Constituents with Therapeutic Potential in Alzheimer's Disease Inhibit Indoleamine 2, 3-Dioxygenase Activity In Vitro
Source:
IOS Press
Properties and Function of Indoleamine 2, 3-Dioxygenase
Source:
Oxford University Press (OUP)
Design and evaluation of a molecular fingerprint involving the transformation of property descriptor values into a binary classification scheme.
Source:
American Chemical Society (ACS)
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
Source:
Springer Science and Business Media LLC
Miniaturized Rotating Disk Intrinsic Dissolution Rate Measurement: Effects of Buffer Capacity in Comparisons to Traditional Wood's Apparatus
Source:
Springer Science and Business Media LLC
Reinstalling Antitumor Immunity by Inhibiting Tumor-Derived Immunosuppressive Molecule IDO through RNA Interference
Source:
The American Association of Immunologists
Nitrobenzofurazan derivatives of N'-hydroxyamidines as potent inhibitors of indoleamine-2,3-dioxygenase 1.
Source:
Elsevier BV
Development and evaluation of an integrated virtual screening strategy by combining molecular docking and pharmacophore searching based on multiple protein structures.
Source:
American Chemical Society (ACS)
Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy.
Source:
Springer Science and Business Media LLC
Detailed analysis and follow-up studies of a high-throughput screening for indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors
Source:
Elsevier France-Editions Scientifiques Medicales Elsevier
Discovery and Design of Tricyclic Scaffolds as Protein Kinase CK2 (CK2) Inhibitors through a Combination of Shape-Based Virtual Screening and Structure-Based Molecular Modification
Source:
American Chemical Society (ACS)
An integrated virtual screening approach for VEGFR-2 inhibitors
Source:
American Chemical Society (ACS)
Linking provided by
